2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$18.92+$0.03 (+0.16%)
Price as of Oct 22, 2026 7:30 PM EDT- $137.7MMarket Cap
- -17.45%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$18.92+$0.03 (+0.16%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.89 | ||
Change | +$1.91 (+11.21%) | ||
Open | $18.57 | ||
High | $19.48 | ||
Low | $18.29 | ||
Previous Close | $18.95 | ||
Volume | 54,610 | ||
30-Day Average Volume | 419,916 | ||
1-Week Change | 1.88% | ||
1-Month Change | -32.97% | ||
1-Year Change | -17.45% | ||
3-Year Change | -65.10% | ||
5-Year Change | -94.84% | ||
Fundamentals | |||
Shares Outstanding | 7.3M | ||
Total Assets | $30.7M | ||
Market Cap | $137.7M | ||
Enterprise Value | $130.3M | ||
Period: QTR TTM FY | |||
Revenue | $7.9M | ||
Net Income | -$153.1M | ||
Free Cash Flow | -$29.0M | ||
EBIT | -$153.1M | ||
EBITDA | -$153.0M | ||
Net Working Capital | $5.4M | ||
EPS | -$24.14 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 60 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||
Earnings & Revenue